|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenue [abstract] | |||||
| Revenue and Other Income (Note 13) | |||||
| Costs and Expenses | |||||
| General and administrative (Note 14) | |||||
| Royalty generation and project evaluation, net (Note 15) | |||||
| Depletion, depreciation, and direct royalty taxes (Note 7) | |||||
| Share-based payments (Note 16) | |||||
| Total costs and expenses | |||||
| Income from operations | |||||
| Gain (loss) on revaluation of investments | |||||
| Loss on sale of marketable securities | |||||
| Gain on revaluation of derivative liabilities (Note 9) | |||||
| Equity income from investment in SLM California (Note 6) | |||||
| Foreign exchange loss | |||||
| Gain on debt and receivable modifications | |||||
| Loss on settlements and modifications, net (Notes 4 and 10) | |||||
| Gain (loss) on revaluation and provisioning of receivables (Note 5) | |||||
| Finance expense (Note 10) | |||||
| Settlement gain, net (Note 7) | |||||
| Other losses (Note 17) | |||||
| Impairment charges (Note 7) | |||||
| Income (loss) before income taxes | |||||
| Deferred income tax recovery (expense) (Note 11) | |||||
| Income tax expense (Note 11) | |||||
| Loss for the year | |||||
| Currency translation adjustment | |||||
| Comprehensive loss for the year | |||||
| Basic earnings (loss) per share (in dollars per share) | |||||
| Diluted earnings (loss) per share (in dollars per share) | |||||
| Weighted average number of common shares outstanding - basic (in shares) | |||||
| Weighted average number of common shares outstanding - diluted (in shares) | |||||
Loading...
